Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Franceschi

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
Neuro-Oncology|March 9, 2016
AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastomaAlba A Brandes, Gaetano Finocchiaro, Vittorina Zagonel, et al.
Neuro-Oncology|October 24, 2012
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastomaEnrico Franceschi, Roger Stupp, Martin J van den Bent, et al.
Pathology, Research and Practice|August 20, 2024
TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtypeVincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, et al.
Journal of Neuro-Oncology|June 27, 2022
Machine learning in neuro-oncology: toward novel development fieldsVincenzo Di Nunno, Mario Fordellone, Giuseppe Minniti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trialMichele Reni, Warren Mason, Francesco Zaja, et al.
Oral Oncology|August 10, 2025
The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysisAlicia Tosoni, Vincenzo Di Nunno, Andrea Carlini, et al.
Frontiers in Oncology|July 18, 2020
Rare Primary Central Nervous System Tumors in Adults: An OverviewEnrico Franceschi, Didier Frappaz, Roberta Rudà, et al.
European Journal of Cell Biology|April 30, 2025
Combining prelamin A accumulation and oxidative stress: A strategy to target glioblastomaMaria Vittoria Marvi, Camilla Evangelisti, Camilla Bruna Cerchier, et al.
World Journal of Gastroenterology|June 17, 2021
Molecular alterations in pancreatic tumorsMichela Visani, Giorgia Acquaviva, Antonio De Leo, et al.
Frontiers in Oncology|December 11, 2023
Spinal ependymoma in adults: from molecular advances to new treatment perspectivesGiulia Cerretti, Federico Pessina, Enrico Franceschi, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
Neuro-Oncology|March 9, 2016
AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastomaAlba A Brandes, Gaetano Finocchiaro, Vittorina Zagonel, et al.
Neuro-Oncology|October 24, 2012
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastomaEnrico Franceschi, Roger Stupp, Martin J van den Bent, et al.
Pathology, Research and Practice|August 20, 2024
TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtypeVincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, et al.
Journal of Neuro-Oncology|June 27, 2022
Machine learning in neuro-oncology: toward novel development fieldsVincenzo Di Nunno, Mario Fordellone, Giuseppe Minniti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trialMichele Reni, Warren Mason, Francesco Zaja, et al.
Oral Oncology|August 10, 2025
The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysisAlicia Tosoni, Vincenzo Di Nunno, Andrea Carlini, et al.
Frontiers in Oncology|July 18, 2020
Rare Primary Central Nervous System Tumors in Adults: An OverviewEnrico Franceschi, Didier Frappaz, Roberta Rudà, et al.
European Journal of Cell Biology|April 30, 2025
Combining prelamin A accumulation and oxidative stress: A strategy to target glioblastomaMaria Vittoria Marvi, Camilla Evangelisti, Camilla Bruna Cerchier, et al.
World Journal of Gastroenterology|June 17, 2021
Molecular alterations in pancreatic tumorsMichela Visani, Giorgia Acquaviva, Antonio De Leo, et al.
Frontiers in Oncology|December 11, 2023
Spinal ependymoma in adults: from molecular advances to new treatment perspectivesGiulia Cerretti, Federico Pessina, Enrico Franceschi, et al.
Pageof 17